Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Ranolazine Attenuates Mechanical Allodynia Associated with Demyelination Injury.
Dynamics of sodium channel Nav1.5 expression in astrocytes in mouse models of multiple sclerosis.
Immune- and miRNA-response to recombinant interferon beta-1a: a biomarker evaluation study to guide the development of novel type I interferon- based therapies.
Electrodiagnostic criteria for Guillain-Barrè syndrome: A critical revision and the need for an update.
Body mass index and waist circumference in persons aging with muscular dystrophy, multiple sclerosis, post-polio syndrome, and spinal cord injury.
Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using optical coherence tomography.
Social and economic burden of walking and mobility problems in multiple sclerosis.
Disruption of nodal architecture in skin biopsies of patients with demyelinating neuropathies.
Acute disseminated encephalomyelitis, transverse myelitis, and neuromyelitis optica.
Leukemia inhibitory factor inhibits T helper 17 cell differentiation and confers treatment effects of neural progenitor cell therapy in autoimmune disease.
The prevalence of incidental findings in multiple sclerosis patients.
Prevalence of multiple sclerosis in Al Quseir city, Red Sea Governorate, Egypt.
Multiple sclerosis: Repurposing dopaminergic drugs for MS - the evidence mounts.
Robotic therapy: the tipping point.
Myelination: Do Astrocytes Play a Role?
Longitudinally extensive transverse myelitis in neuromyelitis optica: a prospective study of 13 Caucasian patients and literature review.
MRI measures should be a primary outcome endpoint in Phase III randomized, controlled trials in multiple sclerosis: Yes.
Meta-analysis of three different types of fatigue management interventions for people with multiple sclerosis: exercise, education, and medication.
Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later.
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis.
Role of serine proteases in inflammation: Bowman-Birk protease inhibitor (BBI) as a potential therapy for autoimmune diseases.
Predictors of long-term outcome in multiple sclerosis patients treated with interferon beta.
Nitric oxide inhibits CXCL12 expression in neuroinflammation.
Cladribine: mode of action and implications for treatment of multiple sclerosis.
Cognitive Trajectories in 4 Patients With Pediatric-Onset Multiple Sclerosis: Serial Evaluation Over a Decade.

Pages